lovastatin biosynthetic process (Q112998147)

The chemical reactions and pathways resulting in the formation of lovastatin (also known as mevinolin, mevacor or monacolin K), a hypolipidemic inhibitor of (3S)-hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase (HMGR).

monacolin K anabolism
GO:0140735
mevinolin biosynthetic process
monacolin K biosynthetic process
mevacor biosynthetic process
mevacor anabolism
mevacor formation
mevacor biosynthesis
lovastatin formation
mevinolin anabolism
mevinolin synthesis
lovastatin synthesis
mevinolin formation,
lovastatin biosynthesis
monacolin K synthesis
lovastatin anabolism
monacolin K formation
mevacor synthesis
monacolin K biosynthesis
mevinolin biosynthesis

Language	Label	Description	Also known as
English	lovastatin biosynthetic process	The chemical reactions and pathways resulting in the formation of lovastatin (also known as mevinolin, mevacor or monacolin K), a hypolipidemic inhibitor of (3S)-hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase (HMGR).	monacolin K anabolism GO:0140735 mevinolin biosynthetic process monacolin K biosynthetic process mevacor biosynthetic process mevacor anabolism mevacor formation mevacor biosynthesis lovastatin formation mevinolin anabolism mevinolin synthesis lovastatin synthesis mevinolin formation, lovastatin biosynthesis monacolin K synthesis lovastatin anabolism monacolin K formation mevacor synthesis monacolin K biosynthesis mevinolin biosynthesis